Wound Care
Overview
To represent Wound Care manufacturers to external stakeholders, to raise the profile of tissue viability as a critical service and the role that technology and industry performs in delivering patient outcomes, experience and system efficiency.
Leadership
- Chair - Jonathan Marl, 3M
- Vice Chair - Kirsty Hunt, HARTMANN
Achievements
- Utilised infographics to highlight the burden of wound care to a wide range of stakeholders including National Wound Care Strategy, NHS Supply Chain, clinical communities and NHS England.
- Initiated discussions with NHS England and NHS Supply chain around whole-life system cost for wound care products.
Priorities
- To guide clinical and procurement decision makers to consider and evaluate whole-life system cost for wound care products versus lowest acquisition cost.
- To promote value of appropriate evidence in wound management; working with clinical stakeholders to create awareness of the sector challenges.
- To support the inclusion of patient views and outcomes in decision making.
- Drive for greater alignment from key government stakeholders, including National Wound Care Strategy, NHS Supply Chain and procurement organisations.
Useful Resources
- Click here to view the latest updates, minutes and future meeting dates for the group.
- Drug Tariff Part IX: Position Paper (September 2020)
- Led the development of the industry position on CET.
- Burden of wounds infographic.
- Clinical evidence to support wound care practice.
- Wound Care Product Training Statement (August 2022).
To join the ABHI Wound Care group, contact andrew.davies@abhi.org.uk
“The ABHI Wound Care Group is very useful for our company to be a part of. Membership of ABHI overall, enables us to connect into the UK healthcare system at a high level, with the group helping to make sense of the current healthcare environment.”
Trevor Andrew, Commercial Strategy Manager, L&R Medical & Wound Care Group Vice Chair
